Efficacy and Safety of KAF156 in Combination With LUM-SDF in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria
Clinical trial NCT03167242 · COMPLETED
Trial details
- NCT number
- NCT03167242
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-02
- Primary completion
- 2021-06-14
- Enrollment
- 524
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.